These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5254949)

  • 1. Long-lasting lozenges CU 701-1: dissolution duration time at home in patients with oral mucosal lesions.
    Kutscher AH; Zegarelli EV; Ruiz L; Miya C; Forester J
    Q Natl Dent Assoc; 1969 Apr; 27(3):76-7. PubMed ID: 5254949
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-lasting lozenges CU 701-1: dissolution duration times in patients with oral mucosal lesions.
    Kutscher AH; Zegarelli EV; Ruiz LM; McAdams W; Baker N; Robinson G
    Ann Dent; 1968 Dec; 27(4):149-50. PubMed ID: 4886473
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-lasting lozenge: dissolution duration time in the clinic in patients with oral mucosal lesions.
    Kutscher AH; Zegarelli EV; Ruiz LM; Miller B; Bonfield C
    J Conn State Dent Assoc; 1969 Apr; 43(2):113. PubMed ID: 4976518
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-lasting lozenges with triamcinolone acetonide. Treatment of erosive lichen planus of oral mucosa.
    Zegarelli EV; Kutscher AH; Mehrhof A
    N Y State J Med; 1969 Sep; 69(18):2463-4. PubMed ID: 5257612
    [No Abstract]   [Full Text] [Related]  

  • 5. Dissolution duration times of a modified long-lasting lozenge formulation in patients with oral lesions.
    Kutscher AH; Zegarelli EV; Metzger J; Ruiz L; Burns A; Ellegood C
    J Oral Med; 1969 Apr; 24(2):51-2. PubMed ID: 5257797
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-lasting lozenges: dissolution studies with CU 701-1 in patients with oral lesions and in volunteer (normal) subjects.
    Kutscher AH; Kanig JL; Zegarelli EV; Ruiz L
    Mil Med; 1968 Jun; 133(6):471-3. PubMed ID: 4988426
    [No Abstract]   [Full Text] [Related]  

  • 7. New long-lasting lozenge protectant vehicle for oral mucosal disease.
    Kutscher AH; Zegarelli EV; Ruiz L; Rosell A; Mehrhof A
    N Y State J Med; 1969 Mar; 69(5):687-9. PubMed ID: 5252482
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-lasting lozenges CU 701-1: dissolution-duration time in volunteer dental students.
    Baker N; McAdams W; Kutscher AH; Zegarelli EV; Ruiz LM; Seidman M
    J Am Dent Hyg Assoc; 1968; 42(4):202-3. PubMed ID: 5247529
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-lasting lozenges: effect of cold fluids on dissolution time in the mouth.
    Kutscher AH; Zegarelli EV; Ruiz LM; Mija C; Bonfield C; Robinson G; Seidman M
    Ann Dent; 1969 Mar; 28(1):8-9. PubMed ID: 5251362
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-lasting lozenges containing triamcinolone acetonide in the treatment of oral mucous membrane lesions.
    Zegarelli EV; Kutscher AH; Silvers HF
    Mil Med; 1968 Oct; 133(10):844-7. PubMed ID: 4977121
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-lasting lozenge: effect of dissolution site on dissolution time.
    Kutscher AH; Zegarelli EV; Ruiz LM; Schoenfeld M; Goldstein J
    J Conn State Dent Assoc; 1969 Jan; 43(1):52-3. PubMed ID: 4975085
    [No Abstract]   [Full Text] [Related]  

  • 12. Formulation and characterisation of a buccoadhesive erodible tablet for the treatment of oral lesions.
    Ali J; Khar RK; Ahuja A
    Pharmazie; 1998 May; 53(5):329-34. PubMed ID: 9631501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional and sublesional injection of triamcinolone acetonide for oral lichen planus.
    Sleeper HR
    Yale J Biol Med; 1967 Oct; 40(2):164-5. PubMed ID: 5583295
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenal function during topical oral treatment with triamcinolone acetonide.
    Lehner T; Lyne C
    Br Dent J; 1970 Aug; 129(4):164-7. PubMed ID: 5272474
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of oral lesions.
    Podany J
    Chronicle; 1969 Jan; 32(5):154. PubMed ID: 5248544
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-lasting lozenges: effect of lozenge weight on dissolution time.
    Coan K; Kutscher AH; Zegarelli EV; Ruiz L; Eshelman EG
    J Am Dent Hyg Assoc; 1968; 42(4):203-4. PubMed ID: 5247530
    [No Abstract]   [Full Text] [Related]  

  • 17. Action of benzocaine long-lasting lozenge.
    Kutscher AH; Zegarelli EV; Ruiz LM; Betaque N; Henry T
    J Oral Med; 1968 Oct; 23(4):132-3. PubMed ID: 4886137
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local steroid therapy for oral mucoceles.
    Tashiro H; Tomoyose Y; Shinohara M; Saza H
    Fukuoka Igaku Zasshi; 1983 Nov; 74(11):759-61. PubMed ID: 6676141
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.